Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

62.76
Delayed Data
As of Jun 27
 +0.04 / +0.06%
Today’s Change
45.28
Today|||52-Week Range
63.85
+17.24%
Year-to-Date

Today’s Trading

Previous close62.72
Today’s open62.72
Day’s range62.62 - 63.20
Volume2,330,039
Average volume (3 months)3,231,203
Market cap$30.8B
Dividend yield0.67%
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)+18.93%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+2.58%
P/E ratio36.5
Price/Sales5.46
Price/Book20.80

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-4.18-3.13%
BAXBaxter International...-0.29-0.48%
ALXNAlexion Pharmaceutic...-2.98-2.38%
INCYIncyte Corp-4.36-3.24%
Data as of 06/27/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.53
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts